Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Autogenous Mesenchymal Stem Cell Culture-Derived Signalling Molecules as Enhancers of Bone Formation in Bone Grafting

NCT04998058 is registered in ClinicalTrials.gov with Pontificia Universidade Católica do Rio Grande do Sul as lead sponsor.

NCT NCT04998058
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04998058 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Autogenous Mesenchymal Stem Cell Culture-Derived Signalling Molecules as Enhancers of Bone Formation in Bone Grafting
Lead sponsor
Pontificia Universidade Católica do Rio Grande do Sul
Phase
Phase 1
Overall status
Not yet recruiting
Start date
December 15, 2027
Completion date
December 30, 2028
Enrollment
20 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alveolar bone atrophy, alveolar bone loss, bone loss, alveolar, bone loss, osteoclastic, grafting bone